Komarova SV - Search Results

1

Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites.

Abdelaziz DM, Stone LS, Komarova SV. Abdelaziz DM, et al. Among authors: komarova sv. Breast Cancer Res Treat. 2015 Aug;153(1):9-20. doi: 10.1007/s10549-015-3517-x. Epub 2015 Jul 25. Breast Cancer Res Treat. 2015. PMID: 26208488

2

Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases.

Hussein O, Tiedemann K, Murshed M, Komarova SV. Hussein O, et al. Among authors: komarova sv. Cancer Lett. 2012 Jan 28;314(2):176-84. doi: 10.1016/j.canlet.2011.09.026. Epub 2011 Sep 29. Cancer Lett. 2012. PMID: 22014409

3

Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.

Abdelaziz DM, Stone LS, Komarova SV. Abdelaziz DM, et al. Among authors: komarova sv. Breast Cancer Res Treat. 2014 Jan;143(2):227-37. doi: 10.1007/s10549-013-2799-0. Epub 2013 Dec 11. Breast Cancer Res Treat. 2014. PMID: 24327332

4

Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells.

Rafiei S, Komarova SV. Rafiei S, et al. Among authors: komarova sv. BMC Cancer. 2013 Dec 26;13:605. doi: 10.1186/1471-2407-13-605. BMC Cancer. 2013. PMID: 24370273 Free PMC article.

5

Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis.

Rafiei S, Tiedemann K, Tabariès S, Siegel PM, Komarova SV. Rafiei S, et al. Among authors: komarova sv. Cancer Lett. 2015 Jun 1;361(2):262-70. doi: 10.1016/j.canlet.2015.03.012. Epub 2015 Mar 14. Cancer Lett. 2015. PMID: 25779674

6

Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta.

Abdelaziz DM, Abdullah S, Magnussen C, Ribeiro-da-Silva A, Komarova SV, Rauch F, Stone LS. Abdelaziz DM, et al. Among authors: komarova sv. Bone. 2015 Dec;81:400-406. doi: 10.1016/j.bone.2015.08.001. Epub 2015 Aug 13. Bone. 2015. PMID: 26277094

7

Megakaryocyte-bone cell interactions: lessons from mouse models of experimental myelofibrosis and related disorders.

Stavnichuk M, Komarova SV. Stavnichuk M, et al. Among authors: komarova sv. Am J Physiol Cell Physiol. 2022 Feb 1;322(2):C177-C184. doi: 10.1152/ajpcell.00328.2021. Epub 2021 Dec 15. Am J Physiol Cell Physiol. 2022. PMID: 34910601 Free article. Review.

8

Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation.

Guo Y, Tiedemann K, Khalil JA, Russo C, Siegel PM, Komarova SV. Guo Y, et al. Among authors: komarova sv. Bone. 2008 Aug;43(2):386-393. doi: 10.1016/j.bone.2008.03.026. Epub 2008 Apr 15. Bone. 2008. PMID: 18502714

9

Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.

Fong JE, Le Nihouannen D, Komarova SV. Fong JE, et al. Among authors: komarova sv. J Biol Chem. 2010 Oct 8;285(41):31427-34. doi: 10.1074/jbc.M110.114496. Epub 2010 Aug 2. J Biol Chem. 2010. PMID: 20679341 Free PMC article.

10

Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.

Hussein O, Tiedemann K, Komarova SV. Hussein O, et al. Among authors: komarova sv. Bone. 2011 Feb;48(2):202-11. doi: 10.1016/j.bone.2010.09.006. Epub 2010 Sep 21. Bone. 2011. PMID: 20849994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters